| Pharmaceutical industry financial support for medical education: benefit, or undue influence? | |
| | |
MedLine Citation:
|
PMID: 19723256 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Presently, the pharmaceutical industry funds about half of the costs of continuing medical education (CME) programs in the U.S. This contributes to the ethical problems that pervade the relationship between medicine and the pharmaceutical industry: trustworthiness and conflicts of interest. The problems are exacerbated by rationalizations prevalent on both sides that deny the ethical concerns. Commercialism and commercial bias are highly visible at large CME gatherings, and available data, while scanty, back up the view that physician attendees' subsequent prescribing practices are influenced by the commercial message. The industry believes that it will recoup $3.56 in increased sales for every dollar that it invests in CME. New guidelines instituted by the Accreditation Council for Continuing Medical Education (ACCME) in 2004 may succeed in reducing excessive commercial influence, especially since the Department of Health and Human Services has also warned the industry of possible anti-kickback violations if firewalls are not erected between CME funding and marketing of drugs. Critics counter that early indicators of improvement are lacking. |
| | |
Authors:
|
Howard Brody |
Related Documents
:
|
12546756 - Use of the internet among dermatologists in the united kingdom, sweden and norway. 18447816 - Barriers to continuing medical education in australian prevocational doctors. 16173066 - Continuing medical education reform for competency-based education and assessment. 20386026 - Aoa continuing medical education. 19602226 - Evaluation of the medical student research programme in norwegian medical schools. a su... 11891166 - The medical condition regard scale: measuring reactions to diagnoses. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics Volume: 37 ISSN: 1073-1105 ISO Abbreviation: - Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-09-02 Completed Date: 2009-10-27 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9315583 Medline TA: J Law Med Ethics Country: United States |
Other Details:
|
Languages: eng Pagination: 451-60, 396 Citation Subset: T |
Affiliation:
|
Institute for the Medical Humanities, University of Texas Medical Branch, Galveston, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Conflict of Interest* Drug Industry / economics, ethics* Education, Medical, Continuing / economics, ethics* Humans Training Support / ethics* United States |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: DTC advertising harms patients and should be tightly regulated.
Next Document: The ethical health lawyer: an empirical assessment of moral decision making.